An interventional study of Moderate Potassium/Low Sodium Diet and Moderate Potassium/High Sodium Diet in Cardiovascular Risk Factor, sponsored by University of Delaware. Completed at 1 site in United States. Open to participants aged 22 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-11-05.
Sponsored by University of Delaware · Not applicable, Interventional, and Prevention
The purpose of this study is to determine if dietary potassium can attenuate the deleterious effects of high sodium on blood vessel function in healthy, salt-resistant participants.
Cardiovascular disease remains a major Public Health problem in the U.S. and is the result of diseases such as atherosclerosis and high blood pressure (BP). Several dietary factors have been implicated as risk factors including high sodium and low potassium diets. Indeed, it is well known that excess sodium can increase BP while potassium rich diets have BP lowering properties. While the role of these two nutrients on BP is widely accepted, their impact on the vasculature has received less attention. Endothelial dysfunction, characterized by impaired dilation is an important non-traditional risk factor for atherosclerosis. Data in animal models suggest that salt loading, independent of changes in BP, results in endothelial dysfunction while evidence is mounting that potassium may be beneficial to vascular health. Further, potassium may be more effective in the presence of high sodium however the role of potassium in protecting the vasculature from a high sodium diet in salt-resistant adults has not been explored. A potential mechanism responsible for sodium induced vascular dysfunction is overproduction of reactive oxygen species resulting in reduced nitric oxide (NO) production/ bioavailability. It has been suggested that potassium can counteract sodium's effect by reducing ROS. The central hypothesis is that potassium can protect against the deleterious effects of high sodium on the vasculature by reducing oxidative stress and preserving NO. In this grant, the investigators propose to use a 21-day controlled feeding study to compare the effects of a high sodium diet (300 mmol) combined with either a high (120 mmol) or moderate (65 mmol) amount of potassium and low sodium (50 mmol) combined with moderate potassium (crossover design, diet order sequence randomized) on 2 levels of the vasculature, conduit artery and microvasculature. These experiments will be performed in salt-resistant participants to study the vascular effects alone, independent of changes in BP.
Exclusion Criteria:
Vascular function will be assessed at both the conduit artery and microvascular level after 7 days of the moderate potassium/low sodium diet.
Other: Moderate Potassium/Low Sodium Diet
Vascular function will be assessed at both the conduit artery and microvascular level after 7 days of the moderate potassium/high sodium diet.
Other: Moderate Potassium/High Sodium Diet
Vascular function will be assessed at both the conduit artery and microvascular level after 7 days of the high potassium/high sodium diet.
Other: High Potassium/High Sodium Diet
7 days of the prescribed diet
7 days of the prescribed diet
7 days of the prescribed diet
Conduit artery endothelial-dependent dilation
The change in flow-mediated dilation (FMD) between the 3 diets as assessed by brachial artery FMD
Time frame: on the 7th day of each diet
Arterial Stiffness
Assessed by carotid to femoral artery pulse wave velocity
Time frame: on 7th day of each diet
Wave reflection
Assessed by augmentation index
Time frame: on 7th day of each diet
Endothelial cell expression of oxidative stress marker
Assessed in venous endothelial cells from participants.
Time frame: on the 7th day of each diet
Ambulatory blood pressure
Assessed by 24 hr ambulatory blood pressure monitoring.
Time frame: 7 days
Plan to share: Undecided
No publications or documents are linked to this record.
This study is completed, as verified in Nov 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Delaware